Food and Drug Administration (FDA) has approved a new indication for Wegovy® (semaglutide) injection 2.4 mg, making it the first-and-only prescription anti-obesity medicine for teens with once-weekly dosing. Wegovy® is now also indicated for use in adolescents (≥ 12 years old) with ...